Alzheimer’s & Body Clock: Study Reveals Potential Treatment
- New research from washington University School of Medicine suggests a connection between circadian rhythm disruption and the advancement of Alzheimer's disease, opening potential avenues for therapeutic intervention.
- A study published in Nature Neuroscience by researchers at Washington University School of Medicine in St.
- Musiek, the study's lead author and a neurologist at Washington University, highlighted the meaning of the findings.
“`html
Alzheimer’s Disease Linked to Disrupted Biological Clock, Study finds
Table of Contents
New research from washington University School of Medicine suggests a connection between circadian rhythm disruption and the advancement of Alzheimer’s disease, opening potential avenues for therapeutic intervention.
What the Study Revealed
A study published in Nature Neuroscience by researchers at Washington University School of Medicine in St. louis, Missouri, demonstrates a link between disruptions in the brain’s internal biological clock – the circadian rhythm - and the development of Alzheimer’s disease. Experiments conducted on mouse models revealed that Alzheimer’s disease interferes with the circadian rhythm in specific brain cells, altering the timing and activity of hundreds of genes crucial for brain function.
Professor Erik S. Musiek, the study’s lead author and a neurologist at Washington University, highlighted the meaning of the findings. The team identified that approximately half of the 82 genes in humans already known to be associated with Alzheimer’s risk are regulated by the circadian rhythm. In Alzheimer’s-model mice, these genes exhibited disrupted circadian patterns.
The Role of Circadian Rhythm and Gene Expression
The circadian rhythm,often referred to as the body’s internal clock,regulates numerous physiological processes,including sleep-wake cycles,hormone release,and body temperature. This rhythm is governed by specific genes that cycle on a roughly 24-hour schedule.When this rhythm is disrupted, it can have cascading effects on cellular function and overall health.
The study’s findings suggest that Alzheimer’s disease doesn’t just *result* from genetic factors, but that the *timing* of gene expression is also critical. Disruptions to the circadian rhythm can alter when and how these genes are expressed, potentially contributing to the pathological changes seen in Alzheimer’s disease.
Genes Linked to Alzheimer’s Risk
The research team focused on the 82 genes previously identified as being linked to Alzheimer’s risk. Their analysis revealed that roughly half of these genes are directly influenced by the circadian rhythm. This suggests that interventions aimed at restoring a healthy circadian rhythm could potentially modulate the expression of these genes and mitigate the risk or progression of the disease.
| Category | Details |
|---|---|
| Total Genes Linked to Alzheimer’s Risk | 82 |
| Approximate Percentage Regulated by Circadian Rhythm | 50% |
| Model Organism | Mouse |
YKL-40 and Potential Biomarkers
Professor Musiek’s previous research identified a protein called YKL-40. Elevated levels of YKL-40 have been observed in individuals with Alzheimer’s disease and are thought to be associated with neuroinflammation. The current study builds upon this work, suggesting that YKL-40 levels might potentially be influenced by circadian rhythm disruptions and could potentially serve as a biomarker for early detection or disease progression.
Implications and Future Research
These findings open up exciting new avenues for Alzheimer’s research and treatment. If disrupting the circadian rhythm contributes to the development of Alzheimer’s, then interventions aimed at restoring a healthy biological clock – such as light therapy, timed meals, or medications that regulate